3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Waldenstrom Macroglobulinemia
1
Solitary Fibrous Tumor, Pleural
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Mesothelioma, Malignant
1
Melanoma
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Glioma
1
Fallopian Tube Neoplasms
1
Diffuse Intrinsic Pontine Glioma
1
Chondrosarcoma, Mesenchymal
1
Chondrosarcoma, Clear Cell
1
Chondrosarcoma
1
Anemia
1
Anatomic Stage III Breast Cancer AJCC v8
1
Adult Patients Who Are Receiving Oncologic Care
1
Interventions
durvalumab
8
Bevacizumab
7
tremelimumab
4
lenvatinib
3
atezolizumab
3
Nivolumab
3
Ipilimumab
3
fludarabine
2
Magnetic Resonance Imaging
2
Hepatectomy
2
Gemcitabine
2
Cyclophosphamide
2
Cisplatin
2
trastuzumab deruxtecan
1
toripalimab
1
ropidoxuridine
1
poly ICLC
1
pembrolizumab
1
brodalumab
1
Whole Genome Sequencing
1
Standard of Care
1
Specimen Handling
1
Radiotherapy, Intensity-Modulated
1
Radionuclide Imaging
1
Pluvicto
1
Platinum
1
Paclitaxel
1
Laparoscopy
1
Immunotherapy, Adoptive
1
Immunotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Liver Neoplasms
×
Pharmacogenomic Testing
×
90 days
×
Clear all
No trials found.